
Opinion|Videos|January 27, 2025
Assessing Symptoms, Treatment Decision-Making, and Monitoring
Panelists discuss when to adjust the dosage of current therapies like sertraline vs considering alternative treatments and the factors that guide these decisions, as well as whether treatments with rapid onset, such as zuranolone capsules or brexanolone intravenous (IV) infusion, would be appropriate for cases like Sarah’s, and what factors would influence the choice between these options.
Advertisement
Episodes in this series

Newsletter
Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Psychiatric Times
1
A New and Improved DSM? The American Psychiatric Association Shares Strategy and Roadmap
2
Addressing Co-Occurring ADHD and Autism, With Lauren Kenworthy, PhD
3
January 2026 in Review: Updates on the Psychiatric Treatment Pipeline
4
The Psychopharmacology of Personality Disorders
5






